Carbapenem resistant Acinetobacter baumannii clinical isolates
Three carbapenem-resistant Acinetobacter baumannii genomes for 3 distinct clinical cases. Associated with publication titled: "Clinical use of ampicillin-sulbactam/ceftazidime-avibactam combination therapy for carbapenem-resistant Acinetobacter baumannii complex infections" in Antimicrobial Agents and Chemotherapy